Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,472 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00086879

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France
  • Centre Regional Rene Gauducheau Nantes-Saint Herblain, France
  • Centre Antoine Lacassagne Nice, France
View Trial Details
Completed

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

NCT01465347

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • St. Joseph's Medical Center Barrow Neurology Clinics Phoenix, Arizona, United States
  • University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Completed

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00047294

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer Center at the University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00823797

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +22 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Amgen 386 for Recurrent Glioblastoma

NCT01290263

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Massachusetts, Worcester Worcester, Massachusetts, United States
View Trial Details
Completed

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

NCT01026493

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cancer Research Center of Hawaii Honolulu, Hawaii, United States
  • Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States
View all 17 locations
View Trial Details
Completed

Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients

NCT01149109

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Depatment of Neurosurgery, Charité, University Hospital Berlin Berlin, Germany
  • Department of Neurology, University Hospital Bochum Bochum, Germany
  • Department of Neurology, University Hospital Bonn Bonn, Germany
  • Department of Neurosurgery, University Hospital Cologne Cologne, Germany
View Trial Details

Related conditions